Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
James E. Fickenscher currently holds 425,000 shares of Zynerba Pharmaceuticals, Inc. (ZYNE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James E. Fickenscher has been a net seller of ZYNE stock. They have purchased $501.3K and sold $2.8M worth of shares.
James E. Fickenscher's most recent insider trade was on Oct 10, 2023, when they sold 425,000 shares at $0.00 per share.
James E. Fickenscher serves as Executive at Zynerba Pharmaceuticals, Inc. (ZYNE). They have executed 68 insider transactions totaling $3.3M over their tenure at the company.
James E. Fickenscher holds the position of Executive at Zynerba Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 21 years and currently hold a stake valued at $0.
James E. Fickenscher has shown a selling trading pattern, with $501.3K in total purchases and $2.8M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by James E. Fickenscher was on Dec 11, 2013, when they sold $1.4M worth of AUXL shares. This transaction involved 71,067 shares at $20.37 per share.
James E. Fickenscher currently owns 425,000 shares of Zynerba Pharmaceuticals, Inc. (ZYNE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of James E. Fickenscher's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. James E. Fickenscher has 68 Form 4 filings on record as an insider at Zynerba Pharmaceuticals, Inc..
Set alerts for James E. Fickenscher and 40,000+ other insiders.